Pharmacoeconomic evaluation on three different anti-hypertensive treatments / 药学实践杂志
Journal of Pharmaceutical Practice
; (6): 189-191, 2018.
Article
em Zh
| WPRIM
| ID: wpr-790863
Biblioteca responsável:
WPRO
ABSTRACT
Objective To compare three different anti-hypertension therapeutic projects by pharmacoeconomic evaluation and to find out the best therapeutic project.Methods Retrospective study was used.120 patients with hypertension were ran-domly assigned to group A(fosinopril sodium),group B(valsartan),group C(amlodipine besylate tablet),the therapeutic effects were observed and were evaluated by cost minimization analysis.Results The total efficiency of A,B,C group were 90·7%, 92·3%,92.1%(P>0.05)respectively.The incidence of adverse reaction were 16.7%,7.7%,13.2%(P>0.05)respective-ly.The costs were 287.3 yuan,378.7 yuan and 320.4 yuan respectively.Conclution The effectiveness of the three groups was similar.In terms of pharmacoeconomics,group A was the best therapeutic project.
Texto completo:
1
Base de dados:
WPRIM
Tipo de estudo:
Observational_studies
Idioma:
Zh
Revista:
Journal of Pharmaceutical Practice
Ano de publicação:
2018
Tipo de documento:
Article